Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Neuro-Oncology|March 5, 2025
High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy resistant subgroups and MYC immunohistochemistry as a powerful outcome predictorAlberto Delaidelli, Fares Burwag, Susana Ben-Neriah, et al.International Journal of Cancer|April 24, 2026
Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for GlioblastomaSabra K Salim, Muhammad Vaseem Shaikh, Jeffrey Wei, et al.Journal of Medicinal Chemistry|February 4, 2022
Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 MedulloblastomaNabanita Nawar, Shazreh Bukhari, Ashley A Adile, et al.Science Advances|December 8, 2021
Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrenceDavid Bakhshinyan, Ashley A Adile, Jeff Liu, et al.Pediatric Radiology|January 24, 2026
The current state of artificial intelligence research in pediatric radiology and recommendations for the future: a scoping reviewRakhshan Kamran, Elysa Widjaja, Alex Sy, et al.Cancer Cell|November 11, 2022
Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastomaWilliam D Gwynne, Yujin Suk, Stefan Custers, et al.Nature Communications|December 6, 2022
Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastomaMichelle M Kameda-Smith, Helen Zhu, En-Ching Luo, et al.Science Translational Medicine|July 2, 2025
A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasisShawn C Chafe, Kui Zhai, Nikoo Aghaei, et al.Nature Medicine|August 2, 2024
Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cellsChirayu R Chokshi, Muhammad Vaseem Shaikh, Benjamin Brakel, et al.Pageof 3